lobbying_activities: 1695960

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1695960	01cbecaa-70e4-4cd2-9401-29b3f7cea1ac	Q2	CAPITOL HILL CONSULTING GROUP	72053	ENDO PHARMACEUTICALS	2015	second_quarter	PHA	Issues related to tamper resistant formulation of pharmaceutical drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2015-07-15T11:38:31.073000-04:00